Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 304-309 , September 2006

Plasma adiponectin levels and incident glucose intolerance in Japanese–Brazilians: A seven-year follow-up study

  • Marcio F. Vendramini

      Affiliations

    • Division of Endocrinology, Department of Medicine, Federal University of São Paulo, São Paulo, SP, Brazil
    • ,
  • Sandra R.G. Ferreira

      Affiliations

    • Department of Preventive Medicine, Federal University of São Paulo, São Paulo, SP, Brazil
    • ,
  • Suely G.A. Gimeno

      Affiliations

    • Department of Preventive Medicine, Federal University of São Paulo, São Paulo, SP, Brazil
    • ,
  • Teresa S. Kasamatsu

      Affiliations

    • Division of Endocrinology, Department of Medicine, Federal University of São Paulo, São Paulo, SP, Brazil
    • ,
  • Walkiria L. Miranda

      Affiliations

    • Division of Endocrinology, Department of Medicine, Federal University of São Paulo, São Paulo, SP, Brazil
    • ,
  • Regina S. Moisés

      Affiliations

    • Division of Endocrinology, Department of Medicine, Federal University of São Paulo, São Paulo, SP, Brazil
    • Corresponding Author InformationCorresponding author at: Universidade Federal de São Paulo, Escola Paulista de Medicina, Disciplina de Endocrinologia, Rua Botucatu, 740-2°. andar, 04034-970 São Paulo, SP, Brazil. Tel.: +55 11 5576 4229; fax: +55 11 5579 6636.
    • ,
  • The Japanese–Brazilians Diabetes Study Group

Received 16 November 2005 ,Accepted 8 February 2006.

References 

  1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodishi HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995;270:26746–26749
  2. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 2001;50:1126–1133
  3. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001;507:142–146
  4. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived antiinflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 2001;86:3815–3819
  5. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose derived protein. Diabetes. 2001;50:2094–2099
  6. Hirose H, Kawai T, Yamamoto Y, Taniyama M, Tomita M, Matsubara K, et al. Effects of pioglitazone on metabolic parameters, body fat distribution and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism. 2002;51:314–317
  7. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin—a key adipokine in the metabolic syndrome. Diabet. Obes. Metab. 2005;0:1–17
  8. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57–58
  9. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: The Funagata Study. Diabet. Care. 2003;26:2015–2020
  10. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361:226–228
  11. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabet. Care. 2003;26:3226–3229
  12. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM. Adiponectin and development of type 2 diabetes: The Atherosclerosis Risk in Communities Study. Diabetes. 2004;53:2473–2478
  13. Gimeno SGA, Ferreira SRG, Franco LJ, Hirai AT, Matsumura L, Moisés RS. Prevalence and 7-year incidence of type II diabetes mellitus in a Japanese–Brazilian population: an alarming public health problem. Diabetologia. 2002;45:1635–1638
  14. Gimeno SGA, Osiro K, Matsumura L, Massimino FC, Ferreira SRG Japanese–Brazilians Diabetes Study Group. Glucose intolerance and all-cause motality in Japanese migrants. Diabet. Res. Clin. Pract. 2005;68:147–154
  15. Vieira JG, Nishida SK, Lombardi MT, Tachibana TT, Obara LH, Dalbosco IS, et al. Comparison of the determination of insulin by a monoclonal antibody-based immunofluorimetric assay and by radioimmunoassay. Braz. J. Med. Biol. Res. 1995;28:537–554
  16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  17. K.G.M.M. Alberti, P.Z. Zimmet, for the World Health Organization Consultation, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus, Report of a WHO Consultation, 1999, WHO, Geneva.
  18. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. Hypoadiponectinaemia in South Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration. Diabet. Med. 2004;21:388–392
  19. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism. 2004;53:1–3
  20. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index in the Japanese population. Clin. Sci. 2002;103:137–142
  21. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J. Clin. Endocrinol. Metab. 2002;87:2764–2769
  22. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52:239–243
  23. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb. Vasc. Biol. 2000;20:1595–1599
  24. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, et al. Sexual differentiation, pregnancy, caloric restriction and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 2003;52:268–276
  25. Weyer C, Funahashi T, Tanaka S, Tanaka S, Hotta K, Matsuzawa Y, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001;86:1930–1935
  26. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosin phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51:1884–1888
  27. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia. 2004;47:249–258

PII: S0168-8227(06)00039-8

doi: 10.1016/j.diabres.2006.02.002

Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 304-309 , September 2006

Article Tools

* Image Usage & Resolution